Log in
Log in

  • May 25, 2019 2:08 PM | Deleted user

    NYSSPS was recently interviewed on the Capitol Pressroom with host, Susan Arbetter, to discuss efforts to promote insurance coverage for babies born with a congenital anomaly.

    The Society has launched a campaign to educate policymakers and the public that 1 in 38 New York babies are born with a congenital anomalies like a cleft palate.

    The plastic surgery that is required for many of these children is typically not covered by insurance which turns families to Medicaid. 

    Access the recording:

  • May 24, 2019 4:07 PM | Deleted user

    On Tuesday, May 28, 2019 the New York State legislature will hear public testimony on a proposal to create single payer system in the state.

    The New York Health Act, A.5248/S.3577, would replace traditional health insurance coverage and public health coverage programs with single-payer health coverage, including long-term care, for all New Yorkers. The program would be publicly funded, including existing federal support for Medicaid and Medicare. New Yorkers would not be required to pay premiums, deductibles, co-pays, or out-of network charges.

    This hearing is the first of a series of hearings that will provide an opportunity for comments and suggestions from stakeholders around the state on the New York Health Act.

    NYSSPS leader, Daniel Huang, MD, will testify on behalf of the Society.  The Society plans to cite concerns regarding delays in care, poorer outcomes and economic viability for practices. 

    NYSSPS acknowledges the Sponsor’s efforts to add provisions that remove the requirement for prior authorizations for health care services.  Additionally, we acknowledge the provisions to allow for health care providers to collectively negotiate with New York Health including payment rates and methodologies.

    The Society support solutions that build on the strengths of New York’s current system and will continue to work with the legislature to identify ways to advance healthcare delivery improvements. We strongly oppose the New York Health Plan in its current iteration but hope to work toward a viable plan acceptable to all stakeholders.

    To submit your own testimony, please visit this link for more details. 

  • May 23, 2019 10:47 AM | Deleted user

    In New York, 1 in 38 babies are born with a congenital anomaly. On average, children with congenital anomalies can expect anywhere from three to five surgical procedures throughout their childhood to restore a more normal appearance and function.

    Although insurance carriers may provide coverage for the initial procedures, they may resist coverage of the later stage procedures, claiming they are cosmetic and not medically necessary. Denial or delay of these procedures – which by definition are reconstructive – could lead to long-term physical, functional, and psychological injuries.

    Join us in the campaign to Give Kids a Chance and modify existing laws to ensure there is insurance coverage for congenital anomalies. Learn more >

  • May 11, 2019 6:18 PM | Deleted user


    As many of you know, in 2017, the NYS Department of Health (NYSDOH) implemented an adverse event monitoring program for office-based surgery (OBS) facilities. As part of an initial pilot program that began in 2017, OBS practices were asked to voluntarily file reports with the NYSDOH. Approximately 18% of all OBS practices in NY State voluntarily filed reports with NYSDOH in 2017 and 2018.

    In late 2018, NYSDOH issued a proposed regulation that would have mandated specific annual reporting by all OBS practices. Our Society reviewed the proposed changes to 10 NYCRR 1000 and found that such regulatory changes would require burdensome and costly monitoring/tracking by OBS practices. The proposed regulations could have made office-based surgery economically untenable for small OBS facilities like those run by many plastic surgeons. We filed rational objections during NYSDOH’s public comment period and also brought to the attention of NYSDOH many of the mechanisms, already in place, that facilitate patient safety in the accredited OBS facilities in which board-certified plastic surgeons operate.

    I am pleased to share with you that, following the public comment period in which the NYSSPS vigorously opposed the proposed regulatory changes, NYSDOH announced that OBS practices will not be mandated to report under the OBS monitoring program for 2019. Furthermore, the NYSDOH indicated that alternative data sources for procedural monitoring—that would hopefully be less burdensome—will be sought. 

    We will continue to monitor any proposed changes to the OBS reporting regulations, and work to keep OBS in NYS both safe and economically viable for plastic surgeons and their patients.

    Thank you for your membership to the NYSSPS as is vital to our advocacy efforts - this is but one example!  


    David T. Greenspun, MD, MSc, FACS
    NYSSPS President

  • May 10, 2019 6:21 PM | Deleted user

    NYSSPS is proud to announce that it is working to advance efforts in the state to address insurance coverage for congenital anomalies. With support from ASPS, the Society will educate the public and policymakers on the importance to expedite care for those impacted with by congenital anomalies and seek legislative and regulatory changes to the existing law. More information on how you can become involved will be released in the coming weeks. 

    The 1in38 Campaign will focus it efforts on the following: 


    One in 38 New York babies are born with a congenital anomaly.

    Nationally, of the 120,000 children born annually with congenital anomalies, approximately 40,000 require reconstructive surgery. 

    Although surgeons are able to correct many of these problems, some insurance companies deny or excessively delay access to care by labeling the procedures not medically necessary–“cosmetic,” or “non-functional” in nature.

    Although carriers may provide coverage for initial procedures, they may resist coverage of the later stage procedures by claiming they are cosmetic and/or not medically necessary. 


    Proactively address delays and denials of coverage for procedures and therapies.


    Require all health insurance policies to cover medically necessary procedures and therapies.

  • May 07, 2019 9:52 AM | Deleted user

    The NYS Society of Plastic Surgeons issued its opposition today to the NYS Senate Health Committee to advance legislation that would remove the rights of hospitals and insurance carriers to include standards for credentialing and privileging practices. 

    NYSSPS and ASPS are committed to ensuring  patients have the best care possible, and  believe that, across the practice of medicine, such a commitment requires physicians to: (1) stay abreast of the latest clinical research and standards of care; (2) demonstrate their mastery of the latest knowledge through objective and reliable assessment methods; and (3) integrate this knowledge into their practice. 

    NYSSPS believes the commitment to lifelong learning and clinical practice improvement that board certification and maintenance of certification (MOC) represent are appropriate criteria for hospitals and insurers undergoing credentialing. 

    It does not necessarily think MOC should be a mandated requirement in every state and facility, however, it does believe that S5280/A5140 undercuts the rights of hospitals and insurance carriers to determine what standards are required for participation. 

    The government should not dictate standards to experts on credentialing and privileging committees, as these determinations are made through highly-specialized evaluations. 

    This bill takes decisions that should be in the hands of doctors and places them in the hands of policymakers. Board certification is unquestionably an appropriate criterion to consider in licensure and for credentialing a physician to a hospital staff or an insurance network, and legislative efforts to undermine its relevance are unwise.

    > For the complete memorandum, please contact the NYSSPS office. 

  • April 22, 2019 9:56 AM | Deleted user

    The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, and the exclusively endorsed carrier for the NYSSPS and ASPS®, has announced a $10 million dividend. Since 1976, The Doctors Company has paid more than $425 million in dividends.

    The 2019 dividend, approved by The Doctors Company Board of Governors, will provide a credit of 7 percent to eligible members in ASPS.

    Eligible members will receive this year’s dividend on their annual premium for policy renewals on or after July 1, 2019.

    For more information, please contact:

    Brian Dalton
    Assistant Vice President, Business Development
    The Doctors Company, Northeast Region
    105 Maxess Road, Suite 124, Melville, NY 11747
    Mailing Address: PO Box 1471, East Lansing, MI 48826
    Direct: (631) 248-2701, Toll Free: (800) 748-0465, extension 2701

  • February 18, 2019 5:02 PM | Deleted user

    On February 13, 2019, the New York State Department of Health provided the following advisory to physicians: A written treatment plan in the patient’s medical record is required if a physician prescribes opioids for pain that has lasted for more than three months or past the time of normal tissue healing.

    There are exceptions for patients being treated for:

    • Cancer that is not in remission
    • Hospice or other end-of-life care and
    • Palliative care.

    The treatment plan must follow generally accepted national professional or governmental guidelines, and shall include (but is not limited to) the documentation and discussion of the following clinical criteria within the medical record:

    • Goals for pain management and functional improvement based on diagnosis, and a discussion on how opioid therapy would be tapered to lower dosages or tapered and discontinued if benefits do not outweigh risks;
    • A review with the patient of the risks of and alternatives to opioid treatment; and
    • An evaluation of risk factors for opioid-related harms.

    Such documentation and discussion of the above clinical criteria shall be done, at a minimum, on an annual basis.

    For an example of a generally accepted national governmental guideline for prescribing opioids for chronic pain from the Centers for Disease Control and Prevention (CDC), visit

  • January 24, 2019 5:19 PM | Deleted user

    Tuesday, May 21, 2019

    Albany, NY 

    On Tuesday, May 21st, 2019 you are invited to advocate for your patients and the profession during the annual New York State Society of Plastic Surgeons Annual Advocacy Day. 

    The day will begin with a legislative briefing of the issues and “asks” as well as a discussion on how to maintain and advance relationships with lawmakers.

     Appointments are scheduled to begin at 10:00am and end at 4:00pm. 

    Why Advocate?

    • Advocacy ensures issues affecting plastic surgeons and patients are recognized
    • If you don’t have a seat at the table, you’re on the menu 
    • Regardless of your politics, the consequences of state policy affect your daily practice and cannot be ignored

    Registration is open and available

    ASPS Advocacy Summit

    June 17-19, 2019
    Washington Court Hotel
    525 New Jersey Ave NW
    Washington, DC 20001

    Brought to you by the ASPS Legislative Advocacy Committee and the PlastyPAC Board of Governors

    • Meet with your U.S. Senators and Representative
    • Participate in workshops to learn more about the state, federal and regulatory issues facing the specialty
    • Shape the Society's advocacy agenda by determining ASPS's federal and state policy priorities
    • Learn first-hand from congressional staff, administration liaisons and political analysts about the future of healthcare
    • Network with leaders from ASPS and local, state and regional plastic surgery societies

    As a board-certified plastic surgeon and an ASPS member, you have the experience, knowledge and ideas to inform Congress before they craft and vote on public policy matters affecting the practice of medicine and the care your patients receive.

    Speak with one voice in Washington, D.C. at the 2019 ASPS Advocacy Summit!

    Register Today!

  • November 15, 2018 12:53 PM | Deleted user

    On November 15, 2018, the New York State Society of Plastic Surgeons (NYSSPS), sent a letter to Marcus Friedrich, MD, Chief Medical Officer at the NYS Department of Health, citing concerns regarding the vagueness of the recently released regulations seeking to mandate procedure reports for office-based surgical practices. 

    As written, the Society noted that the proposed regulation does not meet the standards of rule making and lacks specificity in how, when and what the NYS DOH will require of practices, making the opportunity for plastic surgeons to provide meaningful comment as to the impact this will have on their practices null and void.

    NYSSPS appreciates the opportunity to continue to work with the New York State Department of Health in furthering quality improvement while protecting patients.  However, as written, does not support efforts by the DOH to grant itself broad discretion to define what information OBS practices must report, as well as the form, format and timing of such reports. 

    The Society urged DOH to re-publish a proposed regulation that provides the public with a meaningful opportunity to clearly understand the expectations of the department.

    NYSSPS Comment Letter
    Proposed Regulations 

The New York State Society of Plastic Surgeons, Inc (NYSSPS) was founded in 2008 on the guiding principle that New York’s plastic surgeons need an entity focused directly on representing its member's interests at the state / federal legislative and regulatory levels.


c/o Capital Health Consulting
136 State St., Suite 501
Albany, NY 12207

Powered by Wild Apricot Membership Software